Steris (STE) Income from Non-Controlling Interests (2018 - 2026)
Steris (STE) posted quarterly Income from Non-Controlling Interests of $100000.0 for Q1 2026, down 75.0% year-over-year from $400000.0 in Q1 2025, and down 93.33% quarter-over-quarter from $1.5 million in Q4 2025.
Steris (STE) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
Steris' Income from Non-Controlling Interests history runs 9 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 75.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $2.8 million (up 100.0% YoY), while the FY2026 annual figure was $2.8 million, up 100.0% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $100000.0, down from $1.5 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $1.5 million in Q4 2025, with the low at -$507000.0 in Q2 2022.
- The 5-year median for Income from Non-Controlling Interests is $202000.0 (2023), against an average of $269117.6.
- The sharpest annual moves came in 2022 and 2023: Income from Non-Controlling Interests sank 433.68% in 2022, then surged 1801.85% in 2023.
- Steris' Income from Non-Controlling Interests stood at -$503000.0 in 2022, then soared by 140.16% to $202000.0 in 2023, then slumped by 199.01% to -$200000.0 in 2024, then jumped by 850.0% to $1.5 million in 2025, then plunged by 93.33% to $100000.0 in 2026.
- Business Quant data shows STE's Income from Non-Controlling Interests at $100000.0 in Q1 2026, $1.5 million in Q4 2025, and $600000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.29 Bn | 123.81 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.14 Bn | 72.60 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.68 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 19.19 Bn | 18.78 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 900,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | -261,000.00 |
| Dec 31, 2022 | -503,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | -507,000.00 |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | -529,000.00 |
| Sep 30, 2021 | -186,000.00 |